Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hammerstein

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Human Reproduction (Oxford, England)|October 1, 1991
Long-term use of copper-releasing intrauterine devices for contraceptionI Brosens, E E Baulieu, G Benagiano, et al.
Deutsche Medizinische Wochenschrift (1946)|May 29, 1987
[Current status of the tumor risk from oral contraception. The statement of the Standing Committee on Hormone Toxicology of the German Society for Endocrinology]J Hammerstein, H M Bolt, M Breckwoldt, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 1, 1993
Sexual behavior, contraception and the risk of contracting HIVE E Baulieu, G Benagiano, I Brosens, et al.
Brachytherapy|December 3, 2014
Postoperative brachytherapy for endometrial cancer using a ring applicatorBen G L Vanneste, Philip Meijnen, Chris S J Hammerstein, et al.
Contraception|August 1, 1976
Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteersU J Koch, F Lorenz, K Danehl, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Human Reproduction (Oxford, England)|October 1, 1991
Long-term use of copper-releasing intrauterine devices for contraceptionI Brosens, E E Baulieu, G Benagiano, et al.
Deutsche Medizinische Wochenschrift (1946)|May 29, 1987
[Current status of the tumor risk from oral contraception. The statement of the Standing Committee on Hormone Toxicology of the German Society for Endocrinology]J Hammerstein, H M Bolt, M Breckwoldt, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|February 1, 1993
Sexual behavior, contraception and the risk of contracting HIVE E Baulieu, G Benagiano, I Brosens, et al.
Brachytherapy|December 3, 2014
Postoperative brachytherapy for endometrial cancer using a ring applicatorBen G L Vanneste, Philip Meijnen, Chris S J Hammerstein, et al.
Contraception|August 1, 1976
Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteersU J Koch, F Lorenz, K Danehl, et al.
Pageof 10